On the public citation graph

Plasma melatonin is reduced in Huntington's disease

0 signed · 140 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archneur.65.4.482openalex-snapshot
Rapid Eye Movement Sleep Disturbances in Huntington Disease
inferredcites →https://doi.org/10.1001/jamaneurol.2013.6239openalex-snapshot
Circadian Melatonin Rhythm and Excessive Daytime Sleepiness in Parkinson Disease
inferredcites →https://doi.org/10.1001/jamaneurol.2014.65openalex-snapshot
Sleep and Circadian Rhythm Regulation in Early Parkinson Disease
inferredcites →https://doi.org/10.1002/ana.410410521openalex-snapshot
CAG repeat number governs the development rate of pathology in Huntington's disease
inferredcites →https://doi.org/10.1002/mds.870130609openalex-snapshot
Unified Huntington's disease rating scale: A follow up
inferredcites →https://doi.org/10.1007/bf00314781openalex-snapshot
Nocturnal sleep in huntington's disease
inferredcites →https://doi.org/10.1007/s00415-009-5196-1openalex-snapshot
Delayed onset of the diurnal melatonin rise in patients with Huntington’s disease
inferredcites →https://doi.org/10.1016/0092-8674(93)90585-eopenalex-snapshot
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
inferredcites →https://doi.org/10.1016/j.expneurol.2010.12.011openalex-snapshot
Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease
inferredcites →https://doi.org/10.1016/j.expneurol.2012.10.014openalex-snapshot
Circadian and sleep disorder in Huntington's disease
inferredcites →https://doi.org/10.1016/j.parkreldis.2008.10.002openalex-snapshot
Daytime somnolence and nocturnal sleep disturbances in Huntington disease
inferredcites →https://doi.org/10.1016/s1474-4422(09)70178-4openalex-snapshot
Beyond the brain: widespread pathology in Huntington's disease
inferredcites →https://doi.org/10.1093/brain/awt128openalex-snapshot
Progressive sleep and electroencephalogram changes in mice carrying the Huntington’s disease mutation
inferredcites →https://doi.org/10.1093/brain/awt132openalex-snapshot
Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington’s disease
inferredcites →https://doi.org/10.1111/j.1365-2265.2005.02341.xopenalex-snapshot
Phase‐shifts of 24‐h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men
inferredcites →https://doi.org/10.1111/j.1471-4159.2006.03807.xopenalex-snapshot
Blood 5‐hydroxytryptamine, 5‐hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury
inferredcites →https://doi.org/10.1111/j.1742-4658.2006.05322.xopenalex-snapshot
Melatonin
inferredcites →https://doi.org/10.1371/currents.rrn1189openalex-snapshot
Identifying sleep disturbances in Huntington’s disease using a simple disease-focused questionnaire
inferredcites →https://doi.org/10.1371/journal.pone.0069993openalex-snapshot
The Q175 Mouse Model of Huntington’s Disease Shows Gene Dosage- and Age-Related Decline in Circadian Rhythms of Activity and Sleep
inferredcites →https://doi.org/10.1523/jneurosci.3059-11.2011openalex-snapshot
The Melatonin MT1 Receptor Axis Modulates Mutant Huntingtin-Mediated Toxicity
inferredcites →https://doi.org/10.1523/jneurosci.3842-04.2005openalex-snapshot
Disintegration of the Sleep-Wake Cycle and Circadian Timing in Huntington's Disease
inferredcites →https://doi.org/10.5287/ora-aoozay7g6openalex-snapshot
Analysis of non-steady state physiological and pathological processes
inferredcites →https://doi.org/10.5665/sleep.2314openalex-snapshot
Suprachiasmatic Nucleus Neuropeptide Expression in Patients with Huntington's Disease

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4798009openalex-extracted
A Flexible Molecularly Imprinted Electrochemical Sensor Based on Cuxo/Mxene for Quantitative Detection of Melatonin in Human Urine
inferred← citeshttps://doi.org/10.1002/9781118661895.ch21openalex-snapshot
Huntington's Disease and Other Choreas
inferred← citeshttps://doi.org/10.1002/ana.24495openalex-snapshot
Sleep deficits but no metabolic deficits in premanifest H untington's disease
inferred← citeshttps://doi.org/10.1002/brb3.2227openalex-snapshot
Melatonin salvages lead‐induced neuro‐cognitive shutdown, anxiety, and depressive‐like symptoms via oxido‐inflammatory and cholinergic mechanisms
inferred← citeshttps://doi.org/10.1002/cm.21300openalex-snapshot
Microtubule and microtubule associated protein anomalies in psychiatric disease
inferred← citeshttps://doi.org/10.1002/jnr.24320openalex-snapshot
Pathophysiology in the suprachiasmatic nucleus in mouse models of Huntington’s disease
inferred← citeshttps://doi.org/10.1002/jnr.24492openalex-snapshot
Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease
inferred← citeshttps://doi.org/10.1002/mds.26592openalex-snapshot
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
inferred← citeshttps://doi.org/10.1007/978-1-4939-7825-0_17openalex-snapshot
Biofluid Biomarkers in Huntington’s Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-22468-3_22openalex-snapshot
Disruptions of Circadian Rhythms and Sleep/Wake Cycles in Neurologic Disorders
inferred← citeshttps://doi.org/10.1007/978-3-031-88907-3_20openalex-snapshot
Relationship of Melatonin with the Hippocampus
inferred← citeshttps://doi.org/10.1007/978-81-322-2803-5_7openalex-snapshot
Therapeutic Potential of Melatonin in Combination with Other Drugs Against Neurodegeneration
inferred← citeshttps://doi.org/10.1007/978-981-19-7443-4_9openalex-snapshot
Melatonin in Aging and Aging-Related Disorders
inferred← citeshttps://doi.org/10.1007/978-981-97-6695-6_7openalex-snapshot
The Human SCN in Health and Age-Related Neurological Disorders
inferred← citeshttps://doi.org/10.1007/s00115-015-4306-9openalex-snapshot
Morbus Huntington
inferred← citeshttps://doi.org/10.1007/s00210-023-02939-yopenalex-snapshot
Modulation of neural circuits by melatonin in neurodegenerative and neuropsychiatric disorders
inferred← citeshttps://doi.org/10.1007/s00415-020-10334-3openalex-snapshot
The sleep and circadian problems of Huntington’s disease: when, why and their importance
inferred← citeshttps://doi.org/10.1007/s00415-023-11572-xopenalex-snapshot
The updated development of blood-based biomarkers for Huntington’s disease
inferred← citeshttps://doi.org/10.1007/s10522-022-10006-xopenalex-snapshot
Therapeutic potential of melatonin and its derivatives in aging and neurodegenerative diseases
inferred← citeshttps://doi.org/10.1007/s11064-019-02778-5openalex-snapshot
Potential Circadian Rhythms in Oligodendrocytes? Working Together Through Time
inferred← citeshttps://doi.org/10.1007/s11910-023-01274-2openalex-snapshot
Sleep Disorders in Patients with Choreic Syndromes
inferred← citeshttps://doi.org/10.1007/s12017-018-8486-xopenalex-snapshot
Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway–PPAR Gamma, Energy Metabolism and Circadian Rhythms
inferred← citeshttps://doi.org/10.1016/b978-0-12-804074-4.00005-4openalex-snapshot
Sleep and Movement Disorders
inferred← citeshttps://doi.org/10.1016/b978-0-323-95672-7.00022-4openalex-snapshot
The promise of an underappreciated therapeutic target: Sleep and circadian rhythm dysfunction in Huntington's disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-95702-1.00172-xopenalex-snapshot
Huntington's Disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-95735-9.00033-4openalex-snapshot
Neurodegenerative diseases and circadian rhythm dysfunction: A bidirectional nexus
inferred← citeshttps://doi.org/10.1016/bs.irn.2020.02.005openalex-snapshot
Impact of circadian and diurnal rhythms on cellular metabolic function and neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/bs.vh.2024.04.004openalex-snapshot
A circadian clock regulates the blood-brain barrier across phylogeny
inferred← citeshttps://doi.org/10.1016/j.arr.2021.101358openalex-snapshot
Systemic manifestation and contribution of peripheral tissues to Huntington’s disease pathogenesis
inferred← citeshttps://doi.org/10.1016/j.arr.2022.101717openalex-snapshot
Melatonin: Potential avenue for treating iron overload disorders
inferred← citeshttps://doi.org/10.1016/j.arr.2024.102307openalex-snapshot
The mechanisms of mitochondrial abnormalities that contribute to sleep disorders and related neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.bioorg.2022.105642openalex-snapshot
Recent developments in the management of Huntington's disease
inferred← citeshttps://doi.org/10.1016/j.celrep.2019.03.015openalex-snapshot
Circadian Clocks Function in Concert with Heat Shock Organizing Protein to Modulate Mutant Huntingtin Aggregation and Toxicity
inferred← citeshttps://doi.org/10.1016/j.chembiol.2023.07.009openalex-snapshot
Mitochondria-targeted melatonin photorelease supports the presence of melatonin MT1 receptors in mitochondria inhibiting respiration
inferred← citeshttps://doi.org/10.1016/j.expneurol.2016.06.028openalex-snapshot
Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease
inferred← citeshttps://doi.org/10.1016/j.heliyon.2019.e01190openalex-snapshot
Role of immune-pineal axis in neurodegenerative diseases, unraveling novel hybrid dark hormone therapies
inferred← citeshttps://doi.org/10.1016/j.jneumeth.2016.01.009openalex-snapshot
Using Actiwatch to monitor circadian rhythm disturbance in Huntington’ disease: A cautionary note
inferred← citeshttps://doi.org/10.1016/j.jns.2019.116522openalex-snapshot
Multidisciplinary rehabilitation reduces hypothalamic grey matter volume loss in individuals with preclinical Huntington's disease: A nine-month pilot study
inferred← citeshttps://doi.org/10.1016/j.jsmc.2015.08.004openalex-snapshot
Consequences of Circadian Disruption on Neurologic Health
inferred← citeshttps://doi.org/10.1016/j.mcn.2019.02.004openalex-snapshot
Fluid and imaging biomarkers for Huntington's disease
inferred← citeshttps://doi.org/10.1016/j.msom.2022.10.004openalex-snapshot
Sommeil et maladies neurodégénératives
inferred← citeshttps://doi.org/10.1016/j.nbd.2020.104859openalex-snapshot
Effects of exercise on sleep in neurodegenerative disease
inferred← citeshttps://doi.org/10.1016/j.nbd.2020.105029openalex-snapshot
Circadian alterations in patients with neurodegenerative diseases: Neuropathological basis of underlying network mechanisms
inferred← citeshttps://doi.org/10.1016/j.nbd.2021.105451openalex-snapshot
Two hit mitochondrial-driven model of synapse loss in neurodegeneration
inferred← citeshttps://doi.org/10.1016/j.nbscr.2018.07.001openalex-snapshot
Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington's disease
inferred← citeshttps://doi.org/10.1016/j.nbscr.2026.100153openalex-snapshot
Intrinsically Photosensitive Retinal Ganglion Cells: Context-Dependent Resilience and Vulnerability
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2016.09.006openalex-snapshot
Neuroendocrine and neurotrophic signaling in Huntington’s disease: Implications for pathogenic mechanisms and treatment strategies
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2018.12.025openalex-snapshot
The evolutionarily conserved role of melatonin in CNS disorders and behavioral regulation: Translational lessons from zebrafish
inferred← citeshttps://doi.org/10.1016/j.parkreldis.2017.09.013openalex-snapshot
Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2022.160155openalex-snapshot
Environmental microplastic accumulation exacerbates liver ischemia-reperfusion injury in rat: Protective effects of melatonin
inferred← citeshttps://doi.org/10.1016/j.sleep.2024.08.026openalex-snapshot
Sleep fragmentation despite intact rest-activity patterns in premanifest Huntington's disease: An actigraphy study
inferred← citeshttps://doi.org/10.1016/j.sleep.2025.02.032openalex-snapshot
Melatonin for Huntington's Disease (HD) gene carriers with HD-related sleep disturbance - A pilot study
inferred← citeshttps://doi.org/10.1016/j.smrv.2025.102123openalex-snapshot
Melatonin: beyond circadian regulation - exploring its diverse physiological roles and therapeutic potential
inferred← citeshttps://doi.org/10.1016/j.tice.2026.103884openalex-snapshot
Melatonin: A versatile neuroprotective molecule in neurodegenerative diseases: A narrative review
inferred← citeshttps://doi.org/10.1016/j.yfrne.2026.101247openalex-snapshot
The microbiota-gut-brain axis in Huntington’s disease: Evidence, mechanisms and therapeutic opportunities
inferred← citeshttps://doi.org/10.1016/s1474-4422(15)00177-5openalex-snapshot
Treating the whole body in Huntington's disease
inferred← citeshttps://doi.org/10.1021/acsanm.4c04050openalex-snapshot
Molecularly Imprinted Electrochemical Sensor Based on Cu x O/MXene Nanocomposite for Sensing of Melatonin
inferred← citeshttps://doi.org/10.1021/acschemneuro.1c00083openalex-snapshot
Melatonin as an Antiepileptic Molecule: Therapeutic Implications via Neuroprotective and Inflammatory Mechanisms
inferred← citeshttps://doi.org/10.1038/nrneurol.2014.206openalex-snapshot
'The clocks that time us'—circadian rhythms in neurodegenerative disorders
inferred← citeshttps://doi.org/10.1038/s41401-024-01398-2openalex-snapshot
Modulation of autophagy by melatonin and its receptors: implications in brain disorders
inferred← citeshttps://doi.org/10.1038/s41582-021-00577-7openalex-snapshot
Circadian rhythms in neurodegenerative disorders
inferred← citeshttps://doi.org/10.1080/07420528.2020.1842752openalex-snapshot
Melatonin and curcumin reestablish disturbed circadian gene expressions and restore locomotion ability and eclosion behavior in Drosophila model of Huntington’s disease
inferred← citeshttps://doi.org/10.1080/09291016.2024.2430563openalex-snapshot
Exploring melatonin’s therapeutic potential in neurological disorders: a review of current evidence
inferred← citeshttps://doi.org/10.1093/braincomms/fcac278openalex-snapshot
Different depression: motivational anhedonia governs antidepressant efficacy in Huntington’s disease
inferred← citeshttps://doi.org/10.1093/sleep/zsae247openalex-snapshot
Beyond phase shifting: targeting circadian amplitude for light interventions in humans
inferred← citeshttps://doi.org/10.1097/wad.0000000000000243openalex-snapshot
Circadian Rhythms Disturbances in Alzheimer Disease
inferred← citeshttps://doi.org/10.1111/bph.13856openalex-snapshot
Design and validation of the first cell‐impermeant melatonin receptor agonist
inferred← citeshttps://doi.org/10.1111/ene.13630openalex-snapshot
Neurocardiovascular pathology in pre‐manifest and early‐stage Huntington's disease
inferred← citeshttps://doi.org/10.1111/jne.70085openalex-snapshot
Sleep in neurodegenerative diseases: A focus on melatonin, melanin‐concentrating hormone and orexin
inferred← citeshttps://doi.org/10.1111/jpi.12624openalex-snapshot
Increased plasma melatonin in presymptomatic Huntington disease sheep (Ovis aries): Compensatory neuroprotection in a neurodegenerative disease?
inferred← citeshttps://doi.org/10.1111/jpi.12909openalex-snapshot
Biosynthesis of neuroprotective melatonin is dysregulated in Huntington's disease
inferred← citeshttps://doi.org/10.1111/jpi.70037openalex-snapshot
Melatonin Deficits Result in Pathologic Metabolic Reprogramming in Differentiated Neurons
inferred← citeshttps://doi.org/10.1172/jci135026openalex-snapshot
Melatonin inhibits cytosolic mitochondrial DNA–induced neuroinflammatory signaling in accelerated aging and neurodegeneration
inferred← citeshttps://doi.org/10.1172/jci148288openalex-snapshot
Defining circadian disruption in neurodegenerative disorders
inferred← citeshttps://doi.org/10.1177/0748730418790401openalex-snapshot
Circadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington’s Disease
inferred← citeshttps://doi.org/10.1177/18796397241287227openalex-snapshot
Sleep-wake cycle and 24-h motor activity in early-mid Huntington's disease patients: An actigraphy-based study
inferred← citeshttps://doi.org/10.1186/s13024-023-00617-4openalex-snapshot
Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease
inferred← citeshttps://doi.org/10.1186/s40035-023-00340-6openalex-snapshot
Circadian disruption and sleep disorders in neurodegeneration
inferred← citeshttps://doi.org/10.1210/er.2018-00084openalex-snapshot
Melatonin as a Hormone: New Physiological and Clinical Insights
inferred← citeshttps://doi.org/10.1212/cont.0000000000001727openalex-snapshot
Circadian Neurology
inferred← citeshttps://doi.org/10.1371/journal.pgen.1008356openalex-snapshot
Ataxin2 functions via CrebA to mediate Huntingtin toxicity in circadian clock neurons
inferred← citeshttps://doi.org/10.1371/journal.pone.0138848openalex-snapshot
A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease
inferred← citeshttps://doi.org/10.1371/journal.pone.0146480openalex-snapshot
A Metabolic Study of Huntington’s Disease
inferred← citeshttps://doi.org/10.1371/journal.pone.0147583openalex-snapshot
Sex Differences in Circadian Dysfunction in the BACHD Mouse Model of Huntington’s Disease
inferred← citeshttps://doi.org/10.15761/gdt.1000125openalex-snapshot
Endogenous regulator of brain aging and neurodegeneration-One target multiple therapeutic interventions
inferred← citeshttps://doi.org/10.2147/nss.s561326openalex-snapshot
Circadian Rhythm Dysfunction in Neurodegenerative Diseases: A Bidirectional Perspective and Therapeutic Potential
inferred← citeshttps://doi.org/10.2217/nmt.15.45openalex-snapshot
Therapeutic Strategies for Circadian Rhythm and Sleep Disturbances in Huntington Disease
inferred← citeshttps://doi.org/10.24875/kranion.m22000021openalex-snapshot
Trastornos circadianos del sueño y enfermedades neurodegenerativas
inferred← citeshttps://doi.org/10.3233/jhd-150172openalex-snapshot
Analysis of White Adipose Tissue Gene Expression Reveals CREB1 Pathway Altered in Huntington’s Disease
inferred← citeshttps://doi.org/10.3233/jhd-170273openalex-snapshot
A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward
inferred← citeshttps://doi.org/10.3233/jhd-180291openalex-snapshot
Circadian Rhythm, Cognition, and Mood Disorders in Huntington’s Disease
inferred← citeshttps://doi.org/10.3233/jhd-230567openalex-snapshot
Sleep Dysfunction in Huntington’s Disease: Impacts of Current Medications and Prospects for Treatment
inferred← citeshttps://doi.org/10.3233/jhd-230574openalex-snapshot
Sleep and Circadian Rhythm Dysfunction in Animal Models of Huntington’s Disease
inferred← citeshttps://doi.org/10.3233/jhd-230576openalex-snapshot
Sleep Disorders and Circadian Disruption in Huntington’s Disease
inferred← citeshttps://doi.org/10.3233/jhd-230578openalex-snapshot
Sleep, Circadian Rhythms, and Cognitive Dysfunction in Huntington’s Disease
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1885984openalex-snapshot
Isolated orofacial dystonia and facial pain as the inaugural manifestation of anti-NMDAR encephalitis: a case report and literature review
inferred← citeshttps://doi.org/10.3389/fnagi.2017.00170openalex-snapshot
Neurodegeneration and the Circadian Clock
inferred← citeshttps://doi.org/10.3389/fnagi.2025.1637881openalex-snapshot
Dysregulation of melatonin rhythm in Parkinson’s and Huntington’s disease: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.3389/fneur.2025.1693307openalex-snapshot
Dysfunctions of sleep and the circadian rhythm in Huntington’s disease
inferred← citeshttps://doi.org/10.3389/fnins.2020.627330openalex-snapshot
Circadian and Sleep Dysfunctions in Neurodegenerative Disorders—An Update
inferred← citeshttps://doi.org/10.3389/fonc.2022.1009064openalex-snapshot
Circadian disruption and cancer- and treatment-related symptoms
inferred← citeshttps://doi.org/10.3389/fpsyt.2019.00221openalex-snapshot
Sleep Disorders in Huntington’s Disease
inferred← citeshttps://doi.org/10.3390/biology14020129openalex-snapshot
Advances in Huntington’s Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review
inferred← citeshttps://doi.org/10.3390/biology15020189openalex-snapshot
Melatonin as a Guardian of Mitochondria: Mechanisms and Therapeutic Potential in Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.3390/biom10081158openalex-snapshot
Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.3390/biom15040527openalex-snapshot
Oxidative Stress in Huntington’s Disease
inferred← citeshttps://doi.org/10.3390/biomedicines12081777openalex-snapshot
Circadian Interventions in Preclinical Models of Huntington’s Disease: A Narrative Review
inferred← citeshttps://doi.org/10.3390/diseases9040067openalex-snapshot
Empowering Melatonin Therapeutics with Drosophila Models
inferred← citeshttps://doi.org/10.3390/ijms22041561openalex-snapshot
What, When and How to Measure—Peripheral Biomarkers in Therapy of Huntington’s Disease
inferred← citeshttps://doi.org/10.3390/ijms25084401openalex-snapshot
Modulation of the Circadian Rhythm and Oxidative Stress as Molecular Targets to Improve Vascular Dementia: A Pharmacological Perspective
inferred← citeshttps://doi.org/10.3390/jpm12060864openalex-snapshot
Sleep Quality and Related Clinical Manifestations in Huntington Disease
inferred← citeshttps://doi.org/10.3390/metabo14120723openalex-snapshot
Circadian Influences on Brain Lipid Metabolism and Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.3390/molecules30091888openalex-snapshot
Molecular Links Between Circadian Rhythm Disruption, Melatonin, and Neurodegenerative Diseases: An Updated Review
inferred← citeshttps://doi.org/10.3928/00485713-20170413-02openalex-snapshot
Psychiatric Management of Huntington's Disease
inferred← citeshttps://doi.org/10.4103/aomd.aomd_1_19openalex-snapshot
Sleep disturbances in patients with Huntington’s disease: A questionnaire-based study
inferred← citeshttps://doi.org/10.70675/96f0a0e4z6966z4832za883z0d3af59ca07dopenalex-snapshot
Design, synthesis and validation of photo-pharmacological tools for melatonin receptors
inferred← citeshttps://doi.org/10.70675/e07edff7z4f56z4165z8ee2z475c4aafb600openalex-snapshot
Molecular thermodynamic aspects of dissipative structures in oncology, inflammatory and degenerative processes of Central Nervous System diseases
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.